Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-06

Clinical Trial Update: Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palbociclib in advanced acral melanoma with cell cycle gene aberrations; the update does not provide efficacy results or current trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palbociclib (palbociclib)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma | Phase 2 | Status: UNKNOWN